Fangming Zhang

1.7k total citations · 1 hit paper
65 papers, 1.4k citations indexed

About

Fangming Zhang is a scholar working on Molecular Biology, Immunology and Electrical and Electronic Engineering. According to data from OpenAlex, Fangming Zhang has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Immunology and 10 papers in Electrical and Electronic Engineering. Recurrent topics in Fangming Zhang's work include Supercapacitor Materials and Fabrication (5 papers), Advanced battery technologies research (5 papers) and Electrocatalysts for Energy Conversion (5 papers). Fangming Zhang is often cited by papers focused on Supercapacitor Materials and Fabrication (5 papers), Advanced battery technologies research (5 papers) and Electrocatalysts for Energy Conversion (5 papers). Fangming Zhang collaborates with scholars based in China, United States and Russia. Fangming Zhang's co-authors include Ping Wang, Rongqian Wu, Mian Zhou, Haiqing Zhou, Yu Fang, Dongyang Li, Yuxue Mo, Weifeng Dong, Thanjavur S. Ravikumar and Weng-Lang Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Advanced Functional Materials.

In The Last Decade

Fangming Zhang

59 papers receiving 1.4k citations

Hit Papers

Engineering Multilevel Collaborative Catalytic Interfaces... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangming Zhang China 20 359 317 317 237 157 65 1.4k
Sanjiv Dhingra Canada 31 76 0.2× 834 2.6× 145 0.5× 216 0.9× 76 0.5× 110 2.8k
Jingxian Chen China 20 92 0.3× 423 1.3× 129 0.4× 165 0.7× 23 0.1× 68 1.8k
Tao Nie China 21 175 0.5× 517 1.6× 469 1.5× 92 0.4× 36 0.2× 85 1.8k
Wanying Zhang China 17 87 0.2× 540 1.7× 40 0.1× 331 1.4× 32 0.2× 60 1.6k
Yuping Chen China 26 159 0.4× 471 1.5× 256 0.8× 99 0.4× 14 0.1× 81 1.8k
Ying Cao China 20 158 0.4× 437 1.4× 171 0.5× 127 0.5× 9 0.1× 83 1.3k
Yajie Guo China 22 95 0.3× 668 2.1× 48 0.2× 113 0.5× 60 0.4× 64 1.6k
Xiaoying Ji China 24 30 0.1× 603 1.9× 148 0.5× 96 0.4× 17 0.1× 98 1.9k
Qianqian Zhou China 24 45 0.1× 794 2.5× 129 0.4× 277 1.2× 16 0.1× 97 1.9k
Yuling Chen China 21 120 0.3× 347 1.1× 181 0.6× 168 0.7× 8 0.1× 77 1.2k

Countries citing papers authored by Fangming Zhang

Since Specialization
Citations

This map shows the geographic impact of Fangming Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangming Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangming Zhang more than expected).

Fields of papers citing papers by Fangming Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangming Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangming Zhang. The network helps show where Fangming Zhang may publish in the future.

Co-authorship network of co-authors of Fangming Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fangming Zhang. A scholar is included among the top collaborators of Fangming Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangming Zhang. Fangming Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Fangming, et al.. (2025). Inhibition of eCIRP attenuates PANoptosis and renal fibrosis. American Journal of Physiology-Renal Physiology. 329(3). F399–F409.
2.
Zhang, Fangming, Zhijian Hu, Asha Jacob, Max Brenner, & Ping Wang. (2025). An eCIRP inhibitor attenuates fibrosis and ferroptosis in ischemia and reperfusion induced chronic kidney disease. Molecular Medicine. 31(1). 11–11. 4 indexed citations
3.
Zhang, Fangming, Ziyao Zhang, Guofeng Li, et al.. (2024). Engineering Autologous Cell‐Derived Exosomes to Boost Melanoma‐Targeted Radio‐Immunotherapy by Cascade cGAS‐STING Pathway Activation. Small. 21(4). e2408769–e2408769. 5 indexed citations
4.
Ye, Yangdong, Yanan Wang, Xiaoqing Wu, et al.. (2024). Identification and candidate analysis of a new brown planthopper resistance locus in an Indian landrace of rice, paedai kalibungga. Molecular Breeding. 44(7). 45–45. 2 indexed citations
5.
Zhang, Ziyao, Fangming Zhang, Haonan Wang, et al.. (2024). Induced Necroptosis and Its Role in Cancer Immunotherapy. International Journal of Molecular Sciences. 25(19). 10760–10760. 12 indexed citations
6.
Zhang, Fangming, et al.. (2024). TAG-FREE GLYCOSYLATED RHMFG-E8 AS A THERAPY FOR ACUTE KIDNEY INJURY. Shock. 62(2). 286–293.
7.
Zhang, Fangming, Tao Zheng, Xu Yao, et al.. (2023). Adsorption, in vitro digestion and human gut microbiota regulation characteristics of three Poria cocos polysaccharides. Food Science and Human Wellness. 13(3). 1685–1697. 8 indexed citations
8.
Hu, Zhijian, Fangming Zhang, Max Brenner, Asha Jacob, & Ping Wang. (2023). The protective effect of H151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury. American Journal of Physiology-Renal Physiology. 324(6). F558–F567. 14 indexed citations
9.
Zhang, Fangming. (2023). Research on Audience Needs for Slow-Paced Amusement Shows from the Perspective of Uses and Gratification. Journal of Education Humanities and Social Sciences. 14. 529–538. 1 indexed citations
10.
Xi, Lei, Ying Yang, Ying Xu, et al.. (2022). The enhanced genomic 6 mA metabolism contributes to the proliferation and migration of TSCC cells. International Journal of Oral Science. 14(1). 11–11. 15 indexed citations
12.
Zhang, Fangming, Max Brenner, Weng‐Lang Yang, & Ping Wang. (2018). A cold-inducible RNA-binding protein (CIRP)-derived peptide attenuates inflammation and organ injury in septic mice. Scientific Reports. 8(1). 3052–3052. 50 indexed citations
13.
McGinn, Joseph T., Monowar Aziz, Fangming Zhang, et al.. (2018). Cold-inducible RNA-binding protein-derived peptide C23 attenuates inflammation and tissue injury in a murine model of intestinal ischemia-reperfusion. Surgery. 164(6). 1191–1197. 28 indexed citations
14.
Zhang, Fangming, et al.. (2017). Fabrication and Anti-corrosion Performance of Super-hydrophobic Surface Film on Q235 Steel Substrate. Zhongguo fushi yu fanghu xuebao. 36(6). 617–623. 1 indexed citations
15.
Zhao, Yibing, et al.. (2014). Bmp2 and Bmp4 accelerate alveolar bone development. Connective Tissue Research. 56(3). 204–211. 26 indexed citations
16.
Godwin, Andrew K., Weng-Lang Yang, Archna Sharma, et al.. (2014). Blocking Cold-Inducible RNA-Binding Protein Protects Liver From Ischemia-Reperfusion Injury. Shock. 43(1). 24–30. 77 indexed citations
17.
Zhang, Fangming, et al.. (2008). Human adrenomedullin combined with human adrenomedullin binding protein-1 is protective in gut ischemia and reperfusion injury in the rat. Regulatory Peptides. 152(1-3). 82–87. 8 indexed citations
18.
Wu, Rongqian, Weifeng Dong, Mian Zhou, et al.. (2007). Ghrelin Attenuates Sepsis-induced Acute Lung Injury and Mortality in Rats. American Journal of Respiratory and Critical Care Medicine. 176(8). 805–813. 175 indexed citations
19.
Zhang, Fangming & Reuven Rabinovici. (2007). ADENOSINE DEAMINASE ACTING ON RNA 1 ACCELERATES CELL CYCLE THROUGH INCREASED TRANSLATION AND ACTIVITY OF CYCLIN-DEPENDENT KINASE 2. Shock. 27(2). 214–219. 5 indexed citations
20.
Zhang, Fangming, et al.. (2002). Expression and purification of a recombinant form of human aromatase from Escherichia coli. Biochemical Pharmacology. 64(9). 1317–1324. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026